{"transactions":[{"id":697766,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26798,"kind":"organization","name":"Black Robe Capital LLC","position":1,"cik":"0001977553","reported_name":"Black Robe Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":2,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T01:03:05.000Z","date":"2026-07-01","kind":"gift","planned":false,"acquired":false,"shares":3200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19901057,"source":{"system":"sec-edgar","filing":"0001493152-26-036080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315226036080/ownership.xml","form_type":"4"}},{"id":1261185,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-20T02:28:48.000Z","date":"2024-12-02","kind":"gift","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1946135,"source":{"system":"sec-edgar","filing":"0001493152-25-007628","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315225007628/ownership.xml","form_type":"5"}},{"id":1374050,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-06T20:25:02.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":120968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120968,"derivative":{"exercise_price":0.62,"exercise_date":"2025-10-14","expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":120968},"source":{"system":"sec-edgar","filing":"0001731122-24-001719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000173112224001719/ownership.xml","form_type":"4"}},{"id":1514709,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2024-05-16T17:34:37.000Z","date":"2024-03-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on March 16, 2024 pursuant to the Issuer's 2014 Equity Incentive Plan. The common stock options vested immediately."}],"balance_after":100000,"derivative":{"exercise_price":0.08,"expiration_date":"2034-03-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-020169","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315224020169/ownership.xml","form_type":"4"}},{"id":1889766,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-17T23:46:15.000Z","date":"2023-05-05","kind":"other","planned":false,"acquired":true,"shares":20101057,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC (\"HPLLC\"), pro-rata pursuant to their membership interest in HPLLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares."}],"balance_after":26101057,"source":{"system":"sec-edgar","filing":"0000899243-23-013201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924323013201/doc4.xml","form_type":"4"}},{"id":1889765,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-17T23:46:15.000Z","date":"2023-05-05","kind":"other","planned":false,"acquired":true,"shares":398135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC (\"HPLLC\"), pro-rata pursuant to their membership interest in HPLLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares."}],"balance_after":946135,"source":{"system":"sec-edgar","filing":"0000899243-23-013201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924323013201/doc4.xml","form_type":"4"}},{"id":1889764,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-17T23:46:15.000Z","date":"2023-05-05","kind":"other","planned":false,"acquired":false,"shares":79627069,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC (\"HPLLC\"), pro-rata pursuant to their membership interest in HPLLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-013201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924323013201/doc4.xml","form_type":"4"}},{"id":3105189,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T00:44:47.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. 80,000 option shares vested on the date of grant and the remaining 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service."}],"balance_after":230000,"derivative":{"exercise_price":0.75,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001510964-20-000052","document":"wf-form4_159252746741724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000151096420000052/wf-form4_159252746741724.xml","form_type":"4"}},{"id":3903119,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-06T17:34:24.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is durational-based and vests as follows: the option shares vest in twelve (12) equal monthly installments measured from January 1, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.405,"expiration_date":"2028-02-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001683168-18-001601","document":"mcnulty_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000168316818001601/mcnulty_f4.xml","form_type":"4"}},{"id":4302697,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T23:35:34.000Z","date":"2017-03-17","kind":"other","acquired":true,"shares":1450500,"price":0.413,"value":599056.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to that certain Agreement and Plan of Reorganization, dated as of December 30, 2015, by and among CannaVEST Corp., CANNAVEST Merger Sub, Inc., CANNAVEST Acquisition LLC, CanX, Inc, and The Starwood Trust, as the Shareholder Representative."}],"balance_after":1545500,"source":{"system":"sec-edgar","filing":"0001144204-17-029917","document":"v467793_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000114420417029917/v467793_4.xml","form_type":"4"}},{"id":4302696,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T23:35:34.000Z","date":"2016-10-05","kind":"other","acquired":true,"shares":45000,"price":0.405,"value":18225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to that certain Agreement and Plan of Reorganization, dated as of December 30, 2015, by and among CannaVEST Corp., CANNAVEST Merger Sub, Inc., CANNAVEST Acquisition LLC, CanX, Inc, and The Starwood Trust, as the Shareholder Representative."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001144204-17-029917","document":"v467793_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000114420417029917/v467793_4.xml","form_type":"4"}}]}